May 28, 2022

Cancer occurrence after SLE: effects of medication-related factors, disease-related factors and survival from an observational study

Key Points

Key points are not available for this paper at this time.

Abstract

High dosage of CYC and disease-related factors (low SLEDAI-2K, less mucocutaneous and haematologic involvement) were related factors for cancer occurrence after SLE, while no survival difference was observed.

اسأل الذكاء الاصطناعي

Bookmark

اسأل الذكاء الاصطناعي

Bookmark

Cite This Study

Zhao et al. (Sat,) studied this question.

synapsesocial.com/papers/69dd5b2a8557d5ab8f40d2c0 https://doi.org/https://doi.org/10.1093/rheumatology/keac316

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus1996 · 2,573 citations